BNP Paribas Financial Markets’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.5K | Sell |
4,251
-56,930
| -93% | -$53.8K | ﹤0.01% | 5496 |
|
|
2026
Q1 | $56.2K | Sell |
61,181
-16,437
| -21% | -$19.9K | ﹤0.01% | 4632 |
|
|
2025
Q4 | $99.4K | Buy |
77,618
+19,292
| +33% | +$25.9K | ﹤0.01% | 4382 |
|
|
2025
Q3 | $75.8K | Buy |
58,326
+28,500
| +96% | +$37.3K | ﹤0.01% | 4418 |
|
|
2025
Q2 | $35.8K | Buy |
29,826
+9,986
| +50% | +$11.1K | ﹤0.01% | 4375 |
|
|
2025
Q1 | $21.4K | Sell |
19,840
-15,164
| -43% | -$21.3K | ﹤0.01% | 4520 |
|
|
2024
Q4 | $61.3K | Sell |
35,004
-60,002
| -63% | -$112K | ﹤0.01% | 4343 |
|
|
2024
Q3 | $183K | Sell |
95,006
-41,231
| -30% | -$80.7K | ﹤0.01% | 3282 |
|
|
2024
Q2 | $241K | Buy |
136,237
+118,477
| +667% | +$290K | ﹤0.01% | 3035 |
|
|
2024
Q1 | $48.1K | Buy |
17,760
+17,759
| +1,775,900% | +$42.9K | ﹤0.01% | 3574 |
|
|
2023
Q4 | $2 | Hold |
1
| – | – | ﹤0.01% | 3998 |
|
|
2023
Q3 | $3 | Hold |
1
| – | – | ﹤0.01% | 3904 |
|
|
2023
Q2 | $2 | Sell |
1
-23
| -96% | -$45 | ﹤0.01% | 3909 |
|
|
2023
Q1 | $47 | Sell |
24
-263
| -92% | -$520 | ﹤0.01% | 3797 |
|
|
2022
Q4 | $336 | Buy |
287
+23
| +9% | +$28 | ﹤0.01% | 3890 |
|
|
2022
Q3 | $290 | Sell |
264
-5,771
| -96% | -$8.72K | ﹤0.01% | 4578 |
|
|
2022
Q2 | $9.66K | Sell |
6,035
-12,038
| -67% | -$29.8K | ﹤0.01% | 3753 |
|
|
2022
Q1 | $64.9K | Sell |
18,073
-9,864
| -35% | -$34.1K | ﹤0.01% | 3491 |
|
|
2021
Q4 | $110K | Buy |
27,937
+10,592
| +61% | +$49.6K | ﹤0.01% | 3567 |
|
|
2021
Q3 | $114K | Buy |
17,345
+11,260
| +185% | +$74.1K | ﹤0.01% | 3222 |
|
|
2021
Q2 | $37.5K | Sell |
6,085
-23,220
| -79% | -$124K | ﹤0.01% | 3370 |
|
|
2021
Q1 | $132K | Buy |
29,305
+14,746
| +101% | +$81K | ﹤0.01% | 3226 |
|
|
2020
Q4 | $87.4K | Sell |
14,559
-3,316
| -19% | -$21.8K | ﹤0.01% | 3276 |
|
|
2020
Q3 | $133K | Buy |
17,875
+12,043
| +206% | +$83.1K | ﹤0.01% | 2965 |
|
|
2020
Q2 | $23.4K | Sell |
5,832
-15,480
| -73% | -$53.9K | ﹤0.01% | 3330 |
|
|
2020
Q1 | $54.1K | Buy |
21,312
+11,296
| +113% | +$37.1K | ﹤0.01% | 3501 |
|
|
2019
Q4 | $34.9K | Buy |
10,016
+127
| +1% | +$447 | ﹤0.01% | 3828 |
|
|
2019
Q3 | $45.8K | Buy |
9,889
+5,835
| +144% | +$46K | ﹤0.01% | 3526 |
|
|
2019
Q2 | $49.9K | Sell |
4,054
-2,795
| -41% | -$35.6K | ﹤0.01% | 3418 |
|
|
2019
Q1 | $91K | Buy |
6,849
+6,661
| +3,543% | +$70.2K | ﹤0.01% | 3177 |
|
|
2018
Q4 | $1.62K | Sell |
188
-395
| -68% | -$3.08K | ﹤0.01% | 3836 |
|
|
2018
Q3 | $4.37K | Sell |
583
-214
| -27% | -$1.52K | ﹤0.01% | 4113 |
|
|
2018
Q2 | $4.75K | Sell |
797
-8,232
| -91% | -$46.9K | ﹤0.01% | 4118 |
|
|
2018
Q1 | $52.7K | Buy |
9,029
+243
| +3% | +$1.6K | ﹤0.01% | 3533 |
|
|
2017
Q4 | $51.8K | Buy |
8,786
+5,984
| +214% | +$32.8K | ﹤0.01% | 3649 |
|
|
2017
Q3 | $14.1K | Sell |
2,802
-223
| -7% | -$937 | ﹤0.01% | 3765 |
|
|
2017
Q2 | $12.2K | Buy |
3,025
+2,921
| +2,809% | +$13.8K | ﹤0.01% | 3891 |
|
|
2017
Q1 | $592 | Sell |
104
-1,477
| -93% | -$9.36K | ﹤0.01% | 3819 |
|
|
2016
Q4 | $11.5K | Sell |
1,581
-435
| -22% | -$2.73K | ﹤0.01% | 3389 |
|
|
2016
Q3 | $16.1K | Buy |
2,016
+884
| +78% | +$8.12K | ﹤0.01% | 3010 |
|
|
2016
Q2 | $10.2K | Buy |
1,132
+1,063
| +1,541% | +$9.99K | ﹤0.01% | 2906 |
|
|
2016
Q1 | $557 | Sell |
69
-5,617
| -99% | -$40.5K | ﹤0.01% | 2548 |
|
|
2015
Q4 | $61.5K | Sell |
5,686
-190
| -3% | -$1.87K | ﹤0.01% | 2658 |
|
|
2015
Q3 | $47.7K | Buy |
5,876
+3,466
| +144% | +$54.6K | ﹤0.01% | 2904 |
|
|
2015
Q2 | $58.3K | Buy |
2,410
+1,736
| +258% | +$54.8K | ﹤0.01% | 2401 |
|
|
2015
Q1 | $28.4K | Buy |
+674
| New | +$26.6K | ﹤0.01% | 2198 |
|
|
2014
Q4 | – | Sell |
-1,793
| Closed | -$43.9K | – | 2627 |
|
|
2014
Q3 | $43.9K | Buy |
+1,793
| New | +$50.4K | ﹤0.01% | 2674 |
|
|
2014
Q2 | – | Sell |
-55
| Closed | -$2.07K | – | 3890 |
|
|
2014
Q1 | $2.07K | Sell |
55
-292
| -84% | -$12.8K | ﹤0.01% | 2648 |
|
|
2013
Q4 | $13.3K | Buy |
+347
| New | +$10.2K | ﹤0.01% | 2468 |
|
Other funds holding LAB
CC
MCO
LFCM
HBWM
RA
BNP Paribas Financial Markets's LAB Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Standard BioTools (LAB) stake by 93% in Q2 2026, selling an estimated $53.8K and leaving 4,251 shares worth $3.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5496.
BNP Paribas Financial Markets first reported a position in LAB in Q4 2013 and has held it in 49 quarters since. The position peaked at $241K in Q2 2024. 128 funds tracked by Wall St. Rank hold LAB as of Q2 2026.
- BNP Paribas Financial Markets held 4,251 shares of Standard BioTools worth $3.5K as of Q2 2026.
- BNP Paribas Financial Markets sold 56,930 Standard BioTools shares in Q2 2026, an estimated $53.8K.
- Standard BioTools made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5496 holding.
- BNP Paribas Financial Markets first reported a position in Standard BioTools in Q4 2013 and has held it in 49 quarters since.
- BNP Paribas Financial Markets's Standard BioTools position peaked at $241K in Q2 2024.
- 128 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.